MedWatch

Biontech plans to examine mRNA technology for malaria vaccines

Pharmaceutical company Biontech plans to create a vaccine for malaria based on the same mRNA technology as the firm's vaccine for covid-19, which the German company developed in collaboration with Pfizer.

German firm Biontech, which in collaboration with Pfizer has developed one of the most widely-used coronavirus vaccines, now plans to create a vaccine against malaria.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs